Two widely used in vitro systems of Escherichia coli capable of synthesizing murein were evaluated by using high-pressure liquid chromatography for murein analysis. Comparison of the composition of murein synthesized by either a membrane preparation or ether-treated cells with native murein revealed that both in vitro systems failed to synthesize murein that was identical to murein formed in vivo. Furthermore, neither system attached the lipoprotein to the murein. Ether-treated cells, however, were superior to the membrane preparation in catalyzing the formation of the remarkable A2pm-A2pm cross-linkage. In both systems an atypical transpeptidation reaction was found to take place in which exogenously supplied UDP-N-acetylmuramylpentapeptide was directly linked to the murein without participation of the bactoprenol lipid carrier. The direct transpeptidation yields preferentially trimeric peptide bridges with the UDP-linked muramylpentapeptide serving as the acceptor.
Two widely used in vitro systems of Escherichia coli capable of synthesizing murein were evaluated by using high-pressure liquid chromatography for murein analysis. Comparison of the composition of murein synthesized by either a membrane preparation or ether-treated cells with native murein revealed that both in vitro systems failed to synthesize murein that was identical to murein formed in vivo. Furthermore, neither system attached the lipoprotein to the murein. Ether-treated cells, however, were superior to the membrane preparation in catalyzing the formation of the remarkable A2pm-A2pm cross-linkage. In both systems an atypical transpeptidation reaction was found to take place in which exogenously supplied UDP-N-acetylmuramylpentapeptide was directly linked to the murein without participation of the bactoprenol lipid carrier. The direct transpeptidation yields preferentially trimeric peptide bridges with the UDP-linked muramylpentapeptide serving as the acceptor.
Experimental in vitro systems have long been used in studying the complex multistep mechanism of the biosynthesis of the murein sacculus (2, 3, 9, 13, 17) . Clearly, however, the basic problem with this approach is whether the reactions studied in these artificial systems reflect the natural situation of the undisturbed in vivo system. We took advantage of a recently developed highly sensitive method of murein analysis using high-pressure liquid chromatography (HPLC) (4, 11) to evaluate two widely used in vitro systems, a membrane preparation (9, 16 ) and ether-permeabilized cells (12, 13) . The final steps of murein synthesis in these two systems were compared with those of in vivo murein synthesis.
Previous studies have already shown that murein synthesized by membrane preparations lacks various components of the native murein (11 Isolation of in vivo murein. Murein sacculi were prepared by boiling the cells in 4% SDS for 30 min. The sacculi were collected by high-speed centrifugation (100,000 x g, 40 min) and washed with water as described previously (8) .
Murein analysis. For analysis of the composition of the murein, the material was first incubated in 0.01 M Tris hydrochloride buffer (pH 7.4) containing 0.01 M NaCl with a-amylase (100 p.g/ml; Boehringer, Mannheim, Federal Republic of Germany) for 2 h at 37°C followed by pronase E (100 ,ug/ml; E. Merck AG, Darmstadt, Federal Republic of Germany) for 1 h at 60°C. To destroy contaminating lysozyme activity in the pronase preparation, the enzyme had been preincubated for 2 h at 60°C. After the samples were boiled, the murein was then digested overnight in 0.02 M sodium Table 1.) muropeptide (compound II in Fig. 1 ) yielded after DD-endopeptidase treatment Tetra-Tetra (the dimerofdisaccharidetetrapeptide):Tetra-Penta UDP:Penta-UDP:Tetra in a ratio of 1:1:2:4. From these results its trimeric structure, TetraTetra-Penta-UDP, was established (formula II in Fig. 2 ). Both UDP-linked muropeptides were also present in their respective tetrapeptide forms, as shown by DD-carboxypeptidase treatment (1) of compounds I and II. Removal of the terminal D-alanine of the UDP-muramylpentapeptide part of these compounds resulted in products coeluting with the unusual muropeptides, compounds I' and II' (Fig. 1 ), also present in the muramidase digests of in vitro murein.
It seems that, particularly in the transpeptidation reaction leading to the formation of trimers, the UDP-N-acetylmuramylpentapeptide is the preferred substrate. The ratios of UDP-linked dimers to the respective normal dimers were 0.14 for E. coli PA3092 and 0.11 for strain KN126, whereas the ratios of UDP-linked trimers to the respective normal trimers were 1.7 and 1.3, respectively, for the two strains. With the carboxypeptidase-defective mutant JE5683, a ratio of 0.18 was obtained for the dimers and 1.8 for the trimers. Thus, the, amount of UDP-N-acetylmuramyl-containing trimers in proportion to the normal trimers was 10-fold higher than the ratio of the respective dimeric muropeptides.
The total amount of UDP-N-acetylmuramylpeptide-linked muropeptides depended on the concentration of the exogenously supplied UDP-N-acetylmuramylpentapeptide precursor (Table 3 ). In the ether-treated cell system, which contained sufficient endogenous UDP-N-acetylmuramylpentapeptide to allow murein synthesis to take place without the addition of the pentapeptide precursor, none of the unusual muropeptides were formed when no UDP-N-acetylmuramylpentapeptide was added.
Direction of the cross-linking reaction leading to the formna- phosphate (pH 4.8) in the presence of muramidase (20 ,ug/ml) isolated from Chalaropsis sp. according to the procedure of Hash and Rothlauf (7). The degradation products were reduced in borate buffer and the muropeptides were separated by reversed-phase HPLC on a prepacked Hypersil ODS-18 column (3-,um particle size) as described in detail by Glauner and Schwarz (4 In both in vitro systems, the lipoprotein was not attached to the murein; thus, the Arg-Lys-containing muropeptides were absent. The amount of pentapeptide in the murein synthesized by the in vitro systems was high compared to the native murein composition ( Table 2 ). It was shown previously to be even further increased in mutants with defects in two D-alanine carboxypeptidases, penicillin-binding proteins 4 and 5 (11) . The average glycan chain length as calculated from the amount of anhydromuropeptides, which block the reducing ends of the glycan strands (8), was extremely short in the murein synthesized by membrane preparations and was also reduced in the murein from ether-treated cells ( Table 2 ). The degree of cross-linkage, which was almost normal in the membranes, was high in the murein synthesized by ether-permeabilized cells (Table 2) . This is mainly due to an increase in trimeric muropeptides (Table 1) . More important is the fact that the A2pm-A2pm cross bridge, which seems to be important for the attachment of the lipoprotein (4), was totally lacking in murein synthesized by membranes but was present in the murein made by ether-treated cells (Tables 1 and 2) .
Analysis of the unusual muropeptides characteristic of murein synthesized by in vitro systems. Not only the membrane system but also the ether-treated cells gave rise to the formation of some unusual muropeptide structures (Table 1) . At least four major components not present in native murein could be detected in the muramidase digests of murein synthesized in the in vitro systems (indicated by I, I', II, and II' in Fig. 1 ). The elution behavior of these compounds from the HPLC column was that of cross-linked muropeptides and was, therefore, expected to be sensitive to murein-DDendopeptidase, which splits the peptide cross bridges of dimeric and trimeric muropeptides (6, 10) . The material designated compound I (Fig. 1) was isolated, incubated with purified penicillin-insensitive murein-DD-endo-peptidase (10) , and reapplied onto the same HPLC column system (Fig. 1, upper part) . Only two products appeared, UDP-Nacetylmuramylpentapeptide (Penta-UDP) and disaccharide-tetrapeptide (Tetra), indicating that the unknown compound is the dimer (Tetra-Penta-UDP) of these two compounds as shown by structure I in Fig. 2 . Another unusual tion of UDP-N-acetylmuramylpeptide-linked muropeptides. The pentapeptidyl residue was preserved to a large extent (about 50%) in the UDP-N-acetylmuramylpeptide-linked muropeptides synthesized in vitro (Table 4) , indicating an acceptor function of the UDP-N-acetylmuramylpehtapeptide in the cross-linking reaction. Furthermore, the occurrence of UDP-N-acetylmuramyltetrapeptide containing dimers and trimers seemns to result from a secondary action of carboxypeptidases rather than from a donor fultction of the pentapeptide precursor in the transpeptidation reaction. This is suggested by the finding that the pentapeptide carrying UDP-N-acetylmuramyl-linked muropeptides was formed predominantly in a D-alanine carboxypeptidase-defective mutant (dacA dacB) ( however, that in contrast to the membrane system, ethertreated cells were capabid of forming the remarkable A2pm-A2pm cross bridge, which seems to play a crucial role in the attachment of the lipoprotein (4). In addition, the average chain length, although still shorter, was more normal. Therefore, murein synthesized by ether-permeabilized cells more closely resembles hative murein than murein made by membranes. A peculiar finding was the high degree of cross-linkage and, in particular, the high amounts of trimers in the murein from ether-permeabilized cells. A possible explanation could be the absence in the nongrowing ether-treated cells of the cleavage of cross bridges, which has been shown to take place in growing cells (6) .
Murein made either by membranes or by ether-permeabilized cells contains additional muropeptides resulting from an artificial transpeptidation reaction. These in vitro systems catalyze the direct transpeptidation ofthe UDP-N-acetylmuramylpentapeptide precursor without the prior translocation onto the undecaprenylphosphate carrier and the formation of the disaccharide derivative with N-acetylglucosamine, both of which are part of the regular biosynthetic pathway.
The in vivo formation of a disaccharide precursor guarantees the alternating sequence of the amino sugars, as is present in the glycan strands, whereas the coupling of the hydrophilic murein subunits to a lipid carrier mediates the transport of the precursor across the membrane to the murein sacculus. The obvious reason for the direct cross-linking of UDP-Nacetylmuramylpentapeptide is the fact that an artificial situation exists in both in vitro systems: the soluble precursor is supplied from the outside and is therefore within easy reach for the transpeptidases. Two features of the direct trangpeptidation reaction argue against a raldom interference of the UDP-N-acetylmuramylpentapeptide with the formation of cross bridges in general. The transpeptidation is a directional process with one part, necessarily a pentapeptide moiety, playing the role of the donor and another part, which can be either a tetra-or pentapeptide side chain, playing the role of the acceptor (14) . Surprisingly, however, the UDP-N-acetylmuramylpentapeptide predominantly serves as an acceptor in the crosslinking reaction, despite the fact that as a pentapeptide it is well suited to play the role of a donor as well. In this way the UDP-N-acetylmuramylpentapeptide becomes attached to SDS-insoluble murein in ether-treated cells. Presumably, it is the newly synthesized and therefore pentapeptide-enriched part of the SDS-insoluble mnurein that plays the role of the donor (5, 14) . Furthermore, it is interesting that the direct transpeptidation reaction preferentially yields trimeric cross bridges. Thus, the UDP-N-acetylmuramylpentapeptide may not beconsidered a general substitute acceptor. The formation of trimenc peptide bridges requires a suitable constellation of the three peptide chains to be cross-linked. Although the peptide chains of the SDS-insoluble murein have a restricted flexibility, it is reasonable to assume that the soluble UDPlinked pentapeptide precursor can easily be arranged properly to favor the formation of trimeric peptide bridges.
It has been proposed that the growth and division of a rod-shaped murein sacculus is catalyzed by two different enzyme systems, one specifically involved in cell elongation and a second one involved in septum formation (15, 18) . Murein synthesis during cell elongation is characterized by the formation of cylindrical murein, whereas during cell division spherical polar caps are formed. Since murein of spherical cells was found to be rich in muropeptide trimers (B. Glauner, W. K. Kraus, and U. Shwarz, manuscript in preparation), which are the major reaction products of the transpeptidation reaction described here, it is tempting to speculate that the direct transpeptidation of UDP-N-acetylmuramylpentapeptide is catalyzed by the enzyme system normally involved in cell division. This would enable us to specifically study septum formation.
